TP53 and cancer: Targeting mutant p53 protein for cancer treatment offers advantages like - (i) high selectivity to cancer cells, as mutant p53 is not present in normal cells, and (ii) designed peptides and small molecules can further offer specificity and high efficacy to a particular type of mutant p53.